CASE REPORTsuggested by Rystedt et al.,8 the equivalent Onabotulinumtoxin A units utilized in our patient is still only around 35 units, which is significantly below the acceptable maximum 100 Onabotulinumtoxin…
Read More
INTRODUCTION Loss of tissue elasticity and volume are part of aging. These changes have been attributed to alterations in the formation of collagen.1 In the face, such alterations are manifested…
Read More
In their article “Importing Injectables” in the September 2014 issue of the Journal of Drugs in Dermatology, Dr. Kenneth Beer and Karen Rothschild highlighted the possible harm to patients and…
Read More
Every laser practitioner has a tool they simply cannot do without. If it’s left at a satellite office or gets misplaced, then it’s going to be a stressful day. For…
Read More
INTRODUCTIONApproximately 1.5% to 3% of the populations in the United States and Europe have been estimated to have psoriasis.1,2 Those with plaque psoriasis have a high incidence of certain comorbidities,3,4…
Read More
INTRODUCTIONThe landscape of psoriasis therapies underwent a dramatic transformation with the introduction of efficacious biologic therapies. Many of these, such as etanercept (Enbrel®), a tumor necrosis factor-alpha blocker, are widely…
Read More
INTRODUCTIONTopical corticosteroids are the most common pharmacological agents used in the treatment of dermatological conditions.1 Traditionally, ointments have been the preferred choice for dry scaly conditions due to their high…
Read More
INTRODUCTIONFrequently, obtaining high quality tissue samples to confirm clinical diagnoses is an integral part of selecting appropriate treatment options or assessing treatment outcome. While most tissue samples are still collected…
Read More
INTRODUCTIONFrontal brosing alopecia (FFA) is a lymphocyte-mediated primary cicatricial alopecia predominantly affecting the frontal hairline. It was first described by Kossard in 1994. The clinical characteristic of FFA is a…
Read More
INTRODUCTIONBiosimilars are biological products that are highly similar to, and have no clinically meaningful difference from, an already FDA-approved biological product.1 Specifically, biosimilars are highly complex proteins derived from living cell…
Read More
INTRODUCTIONPsoriasis has been associated with an increased risk of cardiovascular (CV) disease and risk factors, especially among patients with severe disease.1 Patients with psoriasis may have an increased risk of…
Read More
INTRODUCTIONOnychomycosis is a chronic fungal infection of the nail unit primarily caused by the dermatophytes T. rubrum and T. mentagrophytes.1,2 The highly refactory nature of the disease is attributed to…
Read More
